An interventional study of Intercostobrachial Nerve Preservation During Modified Radical Mastectomy and Intercostobrachial Nerve Transection During Modified Radical Mastectomy in Breast Cancer and Post Mastectomy Pain, sponsored by Allama Iqbal Medical College. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Allama Iqbal Medical College · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Breast Neoplasms with a site in Pakistan — 8 open to participants now, 15 under way, none of them phase 3. Breast Neoplasms · Pakistan.
Among the 53 studies in Breast Neoplasms with a site in Pakistan, this one is the 39th largest by enrollment of the 40 interventional ones that give a count, is one of 8 that started in 2026, is one of 26 with no phase, reaches primary completion later than 11 of the 14 other live ones, and was the 53rd registered.
14,855 studies on the registry are indexed under Breast Neoplasms; 3,322 are open to participants now.
Browse Breast Neoplasms studies →8 of the 53 studies in Breast Neoplasms with a site in Pakistan are open now. Recruiting first, the newest first:
Pakistan Institute of Living and Learning · Sites in Pakistan
Ages 18+ · Women only
Riphah International University · Sites in Pakistan
Ages 30–60 · Women only
Riphah International University · Sites in Pakistan
Ages 30–65 · Women only
Superior University · Sites in Pakistan
Ages 35–65 · Women only · Healthy volunteers
Liaquat University of Medical & Health Sciences · Sites in Pakistan
Women only
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 2,403 Breast Neoplasms studies recruiting now, 1,575 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.
This study: 18 Years to 75 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 34 is below the median of 72 across 10,914 interventional studies indexed under Breast Neoplasms.
Median enrollment 115 across the 40 interventional studies, 286 across the 13 observational. Of the 34 that completed or were terminated, 11 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 53 have an industry lead sponsor. The 10 most frequent:
Allama Iqbal Medical College is the lead sponsor of 12 studies on the registry; 7 are open to participants now.
Allama Iqbal Medical College has 1 study filed under Breast Neoplasms — fewer than ten, so there is no comparison to draw.
4 of the studies in Breast Neoplasms with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07862426University of LahoreIncentive Spirometry With and Without Transcutaneous Electric Diaphragmatic Stimulation in Post-mastectomy Patients | 2026-12-13 |
| NCT07811635Jinnah Postgraduate Medical CentrePRISM Trial: Partial Breast Versus Whole Breast Radiation in Early Breast Cancer | 2026-12-31 |
| NCT07950683Allama Iqbal Medical CollegeIntercostobrachial Nerve Preservation Versus Transection During Modified Radical Mastectomy | 2027-05-02 |
| NCT07394946Cancer Care Hospital & Research Centre Foundation, LahoreNeoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 53 studies in Breast Neoplasms with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Breast cancer surgery can cause pain and altered sensation in the armpit and upper arm. During modified radical mastectomy, a nerve called the intercostobrachial nerve may be preserved or cut while lymph nodes are removed from the armpit. This randomized study will compare postoperative pain and the time required for axillary dissection between these two approaches. Thirty-four female patients aged 18 to 75 years with stage I or II breast cancer who are undergoing modified radical mastectomy will be assigned to two groups of 17 participants each. Pain will be assessed after surgery and during follow-up for three months, and the duration of axillary dissection will be measured during the operation. The study aims to assess whether preservation of the nerve is associated with less postoperative pain without a substantial increase in dissection time.
This single-center, two-arm randomized controlled trial will be conducted in Surgical Unit I, Jinnah Hospital, Lahore, Pakistan. Eligible female patients undergoing modified radical mastectomy for stage I or II breast cancer will be recruited by non-probability consecutive sampling. Following written informed consent, 34 participants will be randomly assigned in equal numbers to intercostobrachial nerve preservation (n=17) or intercostobrachial nerve transection (n=17) during axillary lymph node dissection. The method of random sequence generation and allocation concealment is not specified in the synopsis and must be documented separately if required by the registry.
The primary objective is to compare postoperative pain. The study synopsis specifies assessment immediately after surgery and at 1, 2 and 3 months; the accompanying case-report questionnaire identifies postoperative day 3 for early pain assessment and month 3 for persistent pain. Pain intensity is recorded on a 0-to-10 pain scale, with 0 representing no pain and 10 representing the worst pain imaginable. Symptoms such as burning, tingling, numbness, shooting pain, and other sensory disturbances in the intercostobrachial nerve distribution will also be documented. Postoperative neuralgia is defined as pain affecting the inner arm or axilla persisting for at least three months after surgery.
The secondary objective is to compare axillary dissection time. An observer will record the time in minutes from the start to the completion of axillary dissection, using a stopwatch. Total operative duration, measured from first skin incision to final skin closure, will also be recorded. Intraoperative complications and postoperative follow-up information will be captured in a structured questionnaire. The protocol proposes descriptive statistics, independent-samples t-tests for quantitative between-group comparisons, chi-square tests for categorical variables, stratification by age and body mass index, and a significance threshold of p \< 0.05. The final statistical analysis plan should specify how repeated pain measurements will be analyzed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Seventeen planned participants will undergo modified radical mastectomy with preservation of the intercostobrachial nerve during axillary lymph node dissection.
Procedure: Intercostobrachial Nerve Preservation During Modified Radical Mastectomy
Seventeen planned participants will undergo modified radical mastectomy with transection (non-preservation) of the intercostobrachial nerve during axillary lymph node dissection.
Procedure: Intercostobrachial Nerve Transection During Modified Radical Mastectomy
During modified radical mastectomy and axillary lymph node dissection, the intercostobrachial nerve is identified and preserved.
During modified radical mastectomy and axillary lymph node dissection, the intercostobrachial nerve is transected rather than preserved.
Postoperative Pain Intensity
Pain intensity is assessed using a 0-to-10 patient-reported pain rating scale described in the protocol as a Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS). The study questionnaire uses whole-number ratings from 0 (no pain) to 10 (worst pain imaginable); higher scores indicate greater pain. Pain in the axillary and upper-arm region is assessed at follow-up visits.
Time frame: Postoperative day 3 and months 1, 2 and 3 after surgery
Duration of Axillary Lymph Node Dissection
Time taken for axillary lymph node dissection, recorded in minutes by a designated observer using a stopwatch. Longer times indicate greater dissection duration.
Time frame: Intra-operatively, from initiation to completion of axillary dissection
Total Operative Time
Total duration of modified radical mastectomy, recorded in minutes from first skin incision until completion of final skin closure.
Time frame: Intra-operatively, from initial skin incision to final skin closure
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for May 2027, 5 months after the start.
Of 2,669 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 5 months is below that.
Counting every sponsor, half of 2,779 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Allama Iqbal Medical College